Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer

Diabetes Care

Volumn 23, Issue 9, 2000, Pages 1343-1347

  Heinemann, L ^a   Klappoth, W ^a   Rave, K ^a   Hompesch, B ^a   Linkeschowa, R ^a   Heise, T ^a  

^a Profil Institute for Metabolic Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NEUTRAL INSULIN; RECOMBINANT HUMAN INSULIN;

ADULT; AEROSOL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIABETES CONTROL; DIABETES MELLITUS; DRUG ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MALE; TREATMENT OUTCOME;

EID: 0033851983     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.9.1343     Document Type: Article

References (21)

1. Mechanisms of macromolecule absorption by the lungs
2. Time-action profile of inhaled insulin
3. Intranasal administration of peptide hormones: Factors affecting transmucosal absorption
4. Biological activity of nasally administered insulin in normal subjects
5. Intranasal administration of insulin with phospholipid as absorption enhancer: Pharmacokinetics in normal subjects
6. The pharmacodynamics and activity of intranasally administered insulin in healthy male volunteers
7. Intranasal insulin therapy: The clinical realities
8. Pulmonary absorption of peptides and proteins
9. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients using the rapid acting insulin analogue [Lys(B28), Pro(B29)]
10. Nebulized insulin effectively lowers postprandial glucose in patients with non-insulin dependent diabetes mellitus (NIDDM)
11. Pharmacological reproducibility of inhaled human insulin pre-meal dosing in patients with type 2 diabetes mellitus (NIDDM)
12. Action profile of the rapid acting insulin analogue B28Asp
13. [Lys(B28), Pro(B29)]-human insulin: A rapidly absorbed analogue of human insulin
14. Time-action profile of the insulin analogue B28Asp
15. Parenteral absorption of insulin from the lung in diabetic children
16. Nicht radioaktives Verfahren zur Messung der Lungenpermeabilitat: Inhalation von Insulin
17. Preliminary study of the efficiency of insulin aerosol delivered by oral inhalation in diabetic patients
18. Intrapulmonary administration of insulin to healthy volunteers
19. Intrasubject differences in pharmacokinetic and pharmacodynamic responses: The immutable problem of present-day treatment
20. The variability in the action of unmodified insulin is more dependent on changes in tissue insulin sensitivity than on insulin absorption
21. Variability of the metabolic effect of soluble insulin and the rapid acting insulin analogue insulin aspart